With the J.P. Morgan Healthcare Conference now over, some analysts are looking back and picking out the "winners and losers" from the conference. Source: BioSpace

There are many unusual things about Shepherd Therapeutics, but one of them is its origin. Source: BioSpace

Strongbridge will fund 70% of the costs of a worldwide pediatric development program to be run by Aeterna Zentaris with customary oversight from a joint steering committee. Source: BioSpace

On Jan. 8, Alder BioPharma announced that its eptinezumab met its primary endpoint in its Phase III PROMISE 2 clinical trial for preventing migraine. Source: BioSpace

After a two year absence, Aveo returned to the halls of the key event with a drug newly approved for use in Europe and possibly poised for approval in the…

Thirty years ago, neurologist Leonard S. Schliefer, MD, PhD, founded Regeneron, a life sciences company dedicated to discovering, developing and bringing new medications to the patients who need them. Source:…

Kymriah became the first CAR-T cell therapy to receive regulatory approval when it was approved by the FDA in August 2017. Source: BioSpace

Chinese interest in the J&J unit comes as the market for diabetes care in China is expected to grow rapidly. Source: BioSpace